Boehringer Ingelheim has appointed Harsha Deshmukh to its Executive Leadership Team. Starting February 1, 2026, he will lead IT and Global Business Services, strengthening the company’s digital transformation.
The Salus Group is realigning its structure: Effective January 1, 2026, Dr. Florian Block becomes the sole Managing Director of Herbaria Kräuterparadies GmbH, deepening the group's integration. After 25 years, Erwin Winkler moves to Bioland e. V. as Head of Market Management.
BAHN-BKK is reshaping its leadership: Christine Enenkel will become CEO on January 1, 2026, while Dominik Dany joins the executive board to support the fund’s strategic development.
Cochlear Germany introduces Dr. Delphine Lindel as a proven expert in strategic product management. The experienced healthcare specialist will immediately assume the position of Group Product Manager.
Dr. Hans-Peter Hubmann was unanimously confirmed as Chairman of DAPI and will continue to lead the institute for another four years.
As of November 1, Annika Hollmann has taken over as Head of Communications at the German Organ Transplantation Foundation (DSO), succeeding Birgit Blome, who is retiring.
As of November 1, 2025, Gregor Müller has taken on the role of Managing Director at Thieme RECOM. The experienced health economist aims to advance digital transformation and expand the company’s product portfolio.
The Supervisory Board of Medios AG has appointed Thomas Meier as CEO effective February 1, 2026. He succeeds Matthias Gaertner, who will remain in office until the end of 2025.
Renowned dentist and author Dr. Johanna Graf becomes Deputy Chair of the Scientific Advisory Board at BEYOND FLUORID, reinforcing the initiative’s scientific independence.
The Federal Assembly of the German Dental Association has elected Dr. Romy Ermler as its new President. Together with Dr. Ralf Hausweiler and Dr. Doris Seiz, she will lead the new Executive Board.
Effective November 1, Philipp Brunner joins Plan.Net Group as the new CFO, succeeding Dr. Ingo Stein. He will oversee all financial operations and strengthen the group’s digital finance strategy.
Chiesi’s leadership team is growing: With Christine Contré and Sven Noffke, Chiesi gains two experienced professionals in Medical Affairs and Legal & Compliance.
STADA has appointed Tomas Mihal as its new Head of Germany and member of the global STADA Executive Committee. The experienced manager will further strengthen the company’s position and drive sustainable growth across all three business segments.
Starting October 2025, Adrian Haack will join the WEFRA LIFE management board. With his international experience, he will drive the agency group’s growth, innovation, and AI transformation.
BeOne Medicines has permanently appointed Walter Gerhard Hafian-Hatzenbichler as Director of Corporate Affairs Germany. He will oversee the company’s strategic communications and public affairs in Germany.
Johnson & Johnson MedTech Germany has appointed Kenneth Garcia Marques as its new Managing Director. With over 20 years of international experience, he brings fresh ideas and leadership to drive the future of MedTech in Germany.
Yvonne Wutzler and Thorsten Mühl from Cosnova have been jointly awarded “CMO of the Year” for the first time – honoring their social-first strategy, innovation, and team spirit.
Dr. Miriam von Felbert takes over as Director of +49 med and patient+, leading the strategic development of good healthcare group with a focus on team building, structure, and growth.
Roche announces the return of Nina Schwab-Hautzinger as the new Head of Group Communications. She will join the Enlarged Corporate Executive Committee in February 2026.
Novartis Germany has appointed Manfred Heinzer as the new Chairman of the Management Board. He succeeds Heinrich Moisa and brings over 30 years of international pharmaceutical experience.
